Non-Executive Chair
Jason Carroll
Mr Carroll brings over 30 years of experience in the field of life sciences and has held senior leadership roles at several multinational pharmaceutical companies including Johnson & Johnson, Janssen Pharmaceutica and iNova Pharmaceuticals.
Through his career background, Mr Carroll brings specialist expertise in both R&D and corporate strategy. His extensive experience in clinical product development includes oversight of successful market access and reimbursement programs for new drug treatments, alongside the delivery of regional M&A and business development strategies with a focus on South-East Asian markets.
Mr Carroll is a substantial shareholder in the company and also serves as CEO of Tryp Therapeutics Inc. (ASX:TYP).


